赛诺菲拟招募数千受试者开展新冠疫苗试验,已在多国讨论购买

2020-05-06 承天蒙 综合报道 澎湃新闻

法国制药商赛诺菲(Sanofi SA)表示,计划在全球范围内招募数千名受试者,用于与英国制药公司葛兰素史克(GlaxoSmithKline Plc)合作开发的新冠病毒疫苗试验。公司还表示,已经与多个国

法国制药商赛诺菲(Sanofi SA)表示,计划在全球范围内招募数千名受试者,用于与英国制药公司葛兰素史克(GlaxoSmithKline Plc)合作开发的新冠病毒疫苗试验。公司还表示,已经与多个国家开始讨论进一步的购买计划。

5月6日,据路透社报道,赛诺菲正在开展两个新冠肺炎疫苗项目,并表示正在探索几种制造方案,包括新的合作,以确保任何一个项目成功的情况下都能保证满足需求。

赛诺菲的巴斯德(Pasteur)部门过去在流感疫苗方面战绩优异。2020年4月,赛诺菲与英国友商葛兰素史克合作,提出了一个候选疫苗,希望2021年该疫苗能够准备就绪。

赛诺菲这次的疫苗将在其流感疫苗Flublok的基础上,引入一种蛋白质抗原,旨在激发人体免疫反应。葛兰素史克将为疫苗贡献其已经已经获批的一种佐剂,该佐剂可以通过增强免疫反应,产生更多的抗体,让免疫力更加持久。

赛诺菲巴斯德高管对路透社表示,公司希望招募数百名受试者,在9月开展早期阶段的试验。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2027488, encodeId=1aee202e4880e, content=<a href='/topic/show?id=bc03e053189' target=_blank style='color:#2F92EE;'>#疫苗试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70531, encryptionId=bc03e053189, topicName=疫苗试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Thu Aug 27 23:05:03 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446111, encodeId=dc781446111a4, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Fri May 08 08:05:03 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548552, encodeId=52af15485526e, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Fri May 08 08:05:03 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027944, encodeId=f389102e944c6, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed May 06 20:05:03 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2027488, encodeId=1aee202e4880e, content=<a href='/topic/show?id=bc03e053189' target=_blank style='color:#2F92EE;'>#疫苗试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70531, encryptionId=bc03e053189, topicName=疫苗试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Thu Aug 27 23:05:03 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446111, encodeId=dc781446111a4, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Fri May 08 08:05:03 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548552, encodeId=52af15485526e, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Fri May 08 08:05:03 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027944, encodeId=f389102e944c6, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed May 06 20:05:03 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2027488, encodeId=1aee202e4880e, content=<a href='/topic/show?id=bc03e053189' target=_blank style='color:#2F92EE;'>#疫苗试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70531, encryptionId=bc03e053189, topicName=疫苗试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Thu Aug 27 23:05:03 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446111, encodeId=dc781446111a4, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Fri May 08 08:05:03 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548552, encodeId=52af15485526e, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Fri May 08 08:05:03 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027944, encodeId=f389102e944c6, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed May 06 20:05:03 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2027488, encodeId=1aee202e4880e, content=<a href='/topic/show?id=bc03e053189' target=_blank style='color:#2F92EE;'>#疫苗试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70531, encryptionId=bc03e053189, topicName=疫苗试验)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=139a316, createdName=wumeihua88, createdTime=Thu Aug 27 23:05:03 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446111, encodeId=dc781446111a4, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Fri May 08 08:05:03 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548552, encodeId=52af15485526e, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Fri May 08 08:05:03 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027944, encodeId=f389102e944c6, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed May 06 20:05:03 CST 2020, time=2020-05-06, status=1, ipAttribution=)]
    2020-05-06 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

姜世勃:广谱抗冠疫苗和药物是战胜新冠疫情的终极武器

在4月23日未来论坛第七期直播中,我们邀请到了复旦大学病原微生物研究所所长姜世勃为我们带来《广谱抗冠疫苗和药物是战胜新冠疫情的终极武器》的主题分享。稿件整理:郭丽洁,中科院生物物理所博士生; 

特朗普称相信年底将能研发出疫苗 专家:不现实

据美国《国会山报》报道,美国总统特朗普此前表示,将通过“曲速行动”快速将疫苗推向市场,相信年底将能够研发出疫苗,目标是到2021年1月份提供3亿份疫苗。然而,这一说法遭遇专家质

NATURE:中低收入国家的儿童疫苗和抗生素使用情况

疫苗可以减少抗生素耐药性的负担,部分因为其可以预防感染,而感染的治疗通常包括使用抗生素。然而,至今为止,我们对于疫苗接种对抗生素消耗的影响仍然不甚了解--尤其是在中低收入国家(LMICs)。

尚未完成临床试验,全球很大疫苗生产商计划生产新冠血清疫苗

尽管尚未完成临床试验,但位于印度的全球最大疫苗生产商计划在两周内开始生产针对新冠病毒的血清疫苗。该公司称,将以合理的价格出售血清疫苗,每支售价约为12欧元。

科普:疫苗是战疫的有效“武器”

今年的世界免疫周是4月24日至30日,主题是“疫苗保护人人”。历史上人类遭遇的天花、脊髓灰质炎等传染病都通过接种疫苗得到了有效控制,在当前的新冠疫情中疫苗更是成为世界的希望。

新冠疫情影响下的疫苗接种:压力增加,个别疫苗出现短缺

山东的袁先生家里有个10个月的宝宝,孩子出生后每个月都要进行的疫苗接种程序被新冠疫情打乱了。